Corvus Pharmaceuticals In...

NASDAQ: CRVS · Real-Time Price · USD
5.42
0.57 (11.75%)
At close: Aug 15, 2025, 3:59 PM
5.43
0.28%
After-hours: Aug 15, 2025, 07:49 PM EDT

Corvus Pharmaceuticals Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Net Income
-45.13M -41.4M -62.29M -56.83M -22.62M -24.86M -27.03M -30.19M -39.02M -40.88M -41.31M -40.73M -36.57M -39.96M -43.24M -6.66M -5.78M -4.64M
Depreciation & Amortization
92K 84K 85K 93K 102K 117K 151K 217K 281K 337K 367K 366K 380K 410K 460K 509K 548K 585K
Stock-Based Compensation
4.05M 3.56M 3M 2.73M 2.58M 2.34M 2.15M 2.19M 2.31M 2.44M 2.69M 2.81M 3.25M 3.75M 4.23M 4.73M 4.92M 5.13M
Other Working Capital
39K -1.17M -2.47M -801K -427K -1.73M -1.45M -1.5M 1.23M 2.3M 1.08M 1.58M -1.39M -1.7M -1.1M -1.77M -872K -26K
Other Non-Cash Items
10.25M 10.75M 35.24M 32.8M 569K 3.06M 4.91M 7.55M 11.4M 12.01M 11.64M 9.8M 7.07M 5.97M 5.07M -32.73M -34.36M -34.9M
Deferred Income Tax
n/a n/a n/a -522K -522K -522K -522K n/a n/a n/a n/a n/a n/a n/a n/a -1.91M -1.91M -1.91M
Change in Working Capital
1.91M -1.53M -1.46M -391K -1.35M -1.12M -3.59M -6.08M -949K -793K 1.41M 3.25M -1.96M -4.52M -3.24M -2.01M -786K 1.53M
Operating Cash Flow
-28.83M -28.53M -25.42M -22.13M -21.24M -20.98M -23.93M -26.32M -27.81M -28.71M -27.02M -26.33M -27.83M -34.35M -36.72M -38.07M -37.37M -34.21M
Capital Expenditures
-149K -36K n/a n/a n/a n/a -34K -38K -303K -307K -273K -274K -9K -5K -5K n/a -76K -76K
Cash Acquisitions
n/a n/a n/a 4.64K 4.64K 4.64K n/a 17.36K 17.36K 14.22K 18.86K -3.14K -3.14K n/a n/a n/a n/a n/a
Purchase of Investments
-86.38M -73.2M -70.12M -61.18M -44.16M -38.59M -47.05M -54.92M -70.58M -52.9M -66.19M -51.38M -34.07M -32.42M -9.36M -11.94M -17.52M -34.45M
Sales Maturities Of Investments
60.49M 50M 42.63M 37.46M 41.88M 49.52M 62.62M 68.91M 70.33M 60.08M 43.16M 30.27M 13.12M 23.57M 30.92M 35.96M 48.08M 56.44M
Other Investing Acitivies
n/a n/a n/a -4.64K -4.64K -8.93K -4.29K 4.35K 3.31M 3.32M -22.26M -24.26M -24.09M -8.86M 21.57M 24.02M 30.57M 21.99M
Investing Cash Flow
-26.03M -23.23M -27.48M -23.72M -2.28M 10.93M 15.54M 13.98M -529K 6.9M -23.28M -21.39M -20.96M -8.86M 21.56M 24.02M 30.49M 21.92M
Debt Repayment
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Common Stock Repurchased
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
n/a n/a n/a n/a 8K 7.52M 7.53M 7.53M 7.52M 4K n/a 18K 1.22M 1.22M 1.22M 2.42M 1.29M 1.31M
Financial Cash Flow
54.71M 49.31M 49.03M 30.42M 30.7M 7.85M 7.86M 7.86M 7.52M 4K n/a 18K 18.35M 29.57M 62.16M 63.36M 45.09M 33.9M
Net Cash Flow
-150K -2.46M -3.88M -15.43M 7.18M -2.2M -539K -4.48M -20.82M -21.81M -50.3M -47.71M -30.44M -13.64M 47M 49.32M 38.21M 21.61M
Free Cash Flow
-28.98M -28.57M -25.42M -22.13M -21.24M -20.98M -23.97M -26.35M -28.11M -29.02M -27.3M -26.61M -27.84M -34.36M -36.72M -38.07M -37.45M -34.29M